These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 30864840)

  • 21. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
    Vaziri ND; Zhao YY; Pahl MV
    Nephrol Dial Transplant; 2016 May; 31(5):737-46. PubMed ID: 25883197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.
    Anders HJ; Andersen K; Stecher B
    Kidney Int; 2013 Jun; 83(6):1010-6. PubMed ID: 23325079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
    Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiome in chronic kidney disease.
    Wing MR; Patel SS; Ramezani A; Raj DS
    Exp Physiol; 2016 Apr; 101(4):471-7. PubMed ID: 26337794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of the Gut Microbiome on Chronic Kidney Disease.
    Sampaio-Maia B; Simões-Silva L; Pestana M; Araujo R; Soares-Silva IJ
    Adv Appl Microbiol; 2016; 96():65-94. PubMed ID: 27565581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD.
    Kortman GAM; Reijnders D; Swinkels DW
    Hemodial Int; 2017 Jun; 21 Suppl 1():S28-S36. PubMed ID: 28328083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.
    Laville SM; Massy ZA; Kamel S; Chillon JM; Choukroun G; Liabeuf S
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33530404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
    Vitetta L; Linnane AW; Gobe GC
    Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects.
    Mertowska P; Mertowski S; Wojnicka J; Korona-Głowniak I; Grywalska E; Błażewicz A; Załuska W
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of gut microbiota on kidney function and pathogenesis.
    Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
    Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gut microbiota and its relationship with chronic kidney disease.
    Plata C; Cruz C; Cervantes LG; Ramírez V
    Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistant starch slows the progression of CKD in the 5/6 nephrectomy mouse model.
    Karaduta O; Glazko G; Dvanajscak Z; Arthur J; Mackintosh S; Orr L; Rahmatallah Y; Yeruva L; Tackett A; Zybailov B
    Physiol Rep; 2020 Oct; 8(19):e14610. PubMed ID: 33038060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota and Intestinal Epithelial Myd88 Signaling Are Crucial for Renal Injury in UUO Mice.
    Watanabe IKM; Andrade-Silva M; Foresto-Neto O; Felizardo RJF; Matheus MAC; Silva RC; Cenedeze MA; Honda TSB; Perandini LAB; Volpini RA; Pacheco-Silva A; Câmara NOS
    Front Immunol; 2020; 11():578623. PubMed ID: 33414781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
    Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
    Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease.
    Evenepoel P; Dejongh S; Verbeke K; Meijers B
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32365480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
    Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.